TABLE 1.
Inhibition of pathogenic enteric bacteria by: |
Improvement in epithelial and mucosal barrier function by: |
Alteration of immuno-regulation by: |
---|---|---|
• decreasing luminal pH • secretion of bacteriocidal proteins • resisting colonization • blocking epithelial binding |
• production of short-chain fatty acids • enhancing mucus production • increasing barrier integrity |
• increasing interleukin-10 and TGFp, and decreasing TNF levels • increasing IgA production |